At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
Catheter ablation to treat paroxysmal atrial fibrillationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
FARA-Free: A Single Arm Pilot Study of Pulsed Field Ablation in the Treatment of Paroxysmal Atrial Fibrillation
In Brief
A clinical study evaluating Catheter ablation to treat paroxysmal atrial fibrillation for Paroxysmal Atrial Fibrillation. Completed, enrolled 15 participants across 1 site.
Detailed Summary
The objective of this pilot study is to confirm that endocardial ablation using the FARAPULSE Ablation System Plus with commercial design devices is both safe and effective for treating drug-resistant paroxysmal atrial fibrillation (PAF).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation
CountriesCroatia
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartJul 2020
First PostedJul 2020
Primary CompletionDec 2021
TodayJul 2026
First PostedJul 16, 2020
Enrollment StartJul 7, 2020
Primary CompletionDec 21, 2021
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 6.0 years ago
Interventions
Catheter ablation to treat paroxysmal atrial fibrillationdevice
A pulmonary vein isolation will be performed using catheter ablation